Boehringer eyes marked sales gain, boosted by animal health

INGELHEIM, Germany, April 5 (Reuters) - Boehringer Ingelheim, Germany's second-largest drugmaker, said on Wednesday it was targeting a marked gain in 2017 revenues, boosted by new animal health businesses it acquired from Sanofi.